首页> 美国卫生研究院文献>Cytotechnology >Antigen-specific inhibition of CD4+ T-cell responses to β-lactoglobulin by its single amino acid-substituted mutant form through T-cell receptor antagonism
【2h】

Antigen-specific inhibition of CD4+ T-cell responses to β-lactoglobulin by its single amino acid-substituted mutant form through T-cell receptor antagonism

机译:抗原特异性抑制CD4 + T细胞通过T细胞受体拮抗作用的单个氨基酸取代突变体形式对β-乳球蛋白的反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

T cell responses can be antagonized by some single amino acid-substituted analogs of a peptide ligand for T-cell receptors (TCR), and these are called TCR antagonists. In this study, we addressed the question of whether TCR antagonism can be elicited by a whole protein antigen carrying a mutated T-cell determinant region corresponding to a TCR antagonist peptide. To clarify this, we examined the ability of a single amino acid-substituted mutant form of bovine β-lactoglobulin (β-Lg) to inhibit three CD4+ T-cell clones recognizing a peptide corresponding to an immunodominant determinant region 119-133 of β-Lg (p119-133). First, we identified pD129A, an analog of p119-133 with a substitution of Ala for 129Asp, as an antagonist which can inhibit the response of two of the three T-cell clones. Then, using a yeast expression system, we prepared a mutant β-Lg (mutD129A) with the same substitution of Ala for 129Asp as that in pD129A. This mutant protein could inhibit the proliferation of the two T-cell clones in a manner similar to the effect of pD129A. From these results we can demonstrate that TCR antagonism can be elicited by peptides naturally processed from a single-substituted mutant protein as well as by the corresponding peptides added exogenously.
机译:T细胞反应可以被T细胞受体(TCR)的某些肽配体的单个氨基酸取代的类似物拮抗,这些被称为TCR拮抗剂。在这项研究中,我们解决了是否可以通过携带对应于TCR拮抗剂肽的突变T细胞决定簇区域的全蛋白抗原引发TCR拮抗作用的问题。为了澄清这一点,我们检查了牛β-乳球蛋白(β-Lg)的单个氨基酸取代突变体形式抑制识别与免疫优势相对应的肽的三个CD4 + T细胞克隆的能力。 β-Lg的决定簇区域119-133(p119-133)。首先,我们将pD129A(p119-133的类似物,用Ala替代 129 Asp)确定为拮抗剂,它可以抑制三个T细胞克隆中两个克隆的应答。然后,使用酵母表达系统,制备了突变的β-Lg(mutD129A),与pD129A一样,Ala取代了 129 Asp。该突变蛋白可以以类似于pD129A的作用的方式抑制两个T细胞克隆的增殖。从这些结果,我们可以证明,TCR拮抗作用可以由从单取代突变蛋白天然加工的肽以及外源添加的相应肽引起。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号